Factor viii pegylated recomb
Products billed under this code include Adynovate.
Payment limit per 1 IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Adynovate.
Payment limit per 1 IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Adynovate | Takeda Pharmaceuticals America, Inc. | 00944-4622-01 | 1 | $2.185 |
| Adynovate | Takeda Pharmaceuticals America, Inc. | 00944-4623-01 | 1 | $2.185 |
| Adynovate | Takeda Pharmaceuticals America, Inc. | 00944-4624-01 | 1 | $2.185 |
| Adynovate | Takeda Pharmaceuticals America, Inc. | 00944-4625-01 | 1 | $2.185 |
| Adynovate | Takeda Pharmaceuticals America, Inc. | 00944-4626-01 | 1 | $2.185 |
| Adynovate | Takeda Pharmaceuticals America, Inc. | 00944-4627-01 | 1 | $2.185 |
| Adynovate | Takeda Pharmaceuticals America, Inc. | 00944-4628-01 | 1 | $2.185 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $2.185 | +$0.066 | 1 IU | Factor viii pegylated recomb | v1, posted September 17, 2026 |
| 3Q26 | $2.119 | −$0.023 | 1 IU | Factor viii pegylated recomb | v1, posted September 15, 2026 |
| 2Q26 | $2.142 | −$0.02 | 1 IU | Factor viii pegylated recomb | v1, posted September 15, 2026 |
| 1Q26 | $2.162 | +$0.065 | 1 IU | Factor viii pegylated recomb | v1, posted September 15, 2026 |
| 4Q25 | $2.097 | −$0.057 | 1 IU | Factor viii pegylated recomb | v1, posted September 8, 2026 |
| 3Q25 | $2.154 | +$0.052 | 1 IU | Factor viii pegylated recomb | v1, posted March 10, 2026 |
| 2Q25 | $2.102 | +$0.003 | 1 IU | Factor viii pegylated recomb | v1, posted March 10, 2026 |
| 1Q25 | $2.099 | +$0.004 | 1 IU | Factor viii pegylated recomb | v1, posted December 19, 2025 |
| 4Q24 | $2.095 | +$0.061 | 1 IU | Factor viii pegylated recomb | v1, posted June 11, 2025 |
| 3Q24 | $2.034 | −$0.019 | 1 IU | Factor viii pegylated recomb | v1, posted June 11, 2025 |
| 2Q24 | $2.053 | +$0.073 | 1 IU | Factor viii pegylated recomb | v1, posted March 11, 2025 |
| 1Q24 | $1.98 | −$0.05 | 1 IU | Factor viii pegylated recomb | v1, posted December 19, 2024 |
| 4Q23 | $2.03 | −$0.076 | 1 IU | Factor viii pegylated recomb | v1, posted October 10, 2024 |
| 3Q23 | $2.106 | +$0.176 | 1 IU | Factor viii pegylated recomb | v1, posted June 5, 2024 |
| 2Q23 | $1.93 | −$0.094 | 1 IU | Factor viii pegylated recomb | v1, posted February 23, 2024 |
| 1Q23 | $2.024 | −$0.019 | 1 IU | Factor viii pegylated recomb | v1, posted December 6, 2023 |
| 4Q22 | $2.043 | +$0.056 | 1 IU | Factor viii pegylated recomb | v1, posted June 22, 2023 |
| 3Q22 | $1.987 | +$0.061 | 1 IU | Factor viii pegylated recomb | v1, posted June 9, 2023 |
| 2Q22 | $1.926 | −$0.018 | 1 IU | Factor viii pegylated recomb | v1, posted December 14, 2022 |
| 1Q22 | $1.944 | +$0.024 | 1 IU | Factor viii pegylated recomb | v1, posted June 8, 2022 |
| 4Q21 | $1.92 | +$0.002 | 1 IU | Factor viii pegylated recomb | v1, posted June 2, 2022 |
| 3Q21 | $1.918 | +$0.055 | 1 IU | Factor viii pegylated recomb | v1, posted June 2, 2022 |
| 2Q21 | $1.863 | +$0.015 | 1 IU | Factor viii pegylated recomb | v1, posted March 1, 2022 |
| 1Q21 | $1.848 | – | 1 IU | Factor viii pegylated recomb | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.